Cat #: BLP-CT021
Size: 40 µg
Type: Synthetic peptide
Form: Lyophilized Powder
Applications: wb
Application key:
WB- Western blot, IHC- Immunohistochemistry
For research purposes only. not for human use
Properties
Sequence
- Peptide (C)ENSRKAMKEAGKG, corresponding to amino acid residues 626 638 of rat SLC44A1 (Accession Q8VII6).
Accession (Uniprot) Number Q8VII6
Peptide Confirmation Confirmed by amino acid analysis and mass spectrometry.
Purity >70%
Storage Before Reconstitution Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
Reconstitution 100 µl double distilled water (DDW).
Concentration After Reconstitution 0.4 mg/ml.
Storage After Reconstitution -20°C.
Antigen Preadsorption Control 1 µg peptide per 1 µg antibody.
Standard Quality Control Of Each Lot Western blot analysis.
Applications
Demonstration of Pre-adsorption control
- Western blot analysis of rat brain lysates (lanes 1 and 4), mouse brain lysates (lanes 2 and 5) and mouse colon lysates (lanes 3 and 6):1-3. Anti-CTL1 (SLC44A1) (extracellular) Antibody (#ACT-021), (1:200).
4-6. Anti-CTL1 (SLC44A1) (extracellular) Antibody, preincubated with CTL1 (SLC44A1) (extracellular) Blocking Peptide (BLP-CT021). - Western blot analysis of human MCF-7 breast adenocarcinoma cell line lysate (lanes 1 and 4), human Colo 205 colon adenocarcinoma (lanes 2 and 5) and human K562 chronic myelogenous leukemia cell line lysate (lanes 3 and 6):1-3. Anti-CTL1 (SLC44A1) (extracellular) Antibody (#ACT-021), (1:200).
4-6. Anti-CTL1 (SLC44A1) (extracellular) Antibody, preincubated with CTL1 (SLC44A1) (extracellular) Blocking Peptide (BLP-CT021).
Last update: 02/01/2024